RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+2.78%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.04B
AUM Growth
+$1.04B
(-1.3%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
35.44%
Holding
98
New
14
Increased
36
Reduced
31
Closed
5
Top Buys
| 1 |
UnitedHealth
UNH
|
$33M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$10.5M |
| 3 |
Danaher
DHR
|
$9.37M |
| 4 |
Edwards Lifesciences
EW
|
$9.01M |
| 5 |
Elevance Health
ELV
|
$8.83M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$20.8M |
| 2 |
Cigna
CI
|
$20.8M |
| 3 |
Tenet Healthcare
THC
|
$20.1M |
| 4 |
Medtronic
MDT
|
$9.21M |
| 5 |
Natera
NTRA
|
$8.99M |
Sector Composition
| 1 | Healthcare | 99.92% |
| 2 | Industrials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Privia Health
PRVA
$2.84B
| $1.98M | 0.19% |
114,000
| – | – |
|
77
Immunocore
IMCR
$1.78B
| $1.98M | 0.19% |
58,278
-21,500
| -27% | -$729K |
|
78
IDEAYA Biosciences
IDYA
$2.26B
| $1.88M | 0.18% |
+53,500
| New | +$1.88M |
|
|
RVNC
79
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.8M | 0.17% |
701,707
| – | – |
|
80
INmune Bio
INMB
$52.4M
| $1.57M | 0.15% |
178,284
| – | – |
|
81
Relay Therapeutics
RLAY
$709M
| $1.5M | 0.14% |
230,000
| – | – |
|
82
Bio-Techne
TECH
$8.3B
| $1.43M | 0.14% |
20,000
+4,000
| +25% | +$287K |
|
83
Xenon Pharmaceuticals
XENE
$2.99B
| $1.36M | 0.13% |
+35,000
| New | +$1.36M |
|
|
IGMS
84
DELISTED
IGM Biosciences
IGMS
| $1.34M | 0.13% |
195,000
| – | – |
|
85
Amgen
AMGN
$153B
| $1.33M | 0.13% |
4,250
| – | – |
|
86
Pliant Therapeutics
PLRX
$105M
| $1.29M | 0.12% |
120,250
-25,000
| -17% | -$269K |
|
87
Avantor
AVTR
$8.74B
| $1.27M | 0.12% |
60,000
-111,000
| -65% | -$2.35M |
|
88
Repligen
RGEN
$6.54B
| $1.26M | 0.12% |
10,000
+5,000
| +100% | +$630K |
|
89
Medpace
MEDP
$13.5B
| $1.03M | 0.1% |
+2,500
| New | +$1.03M |
|
|
NARI
90
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $963K | 0.09% |
20,000
-36,420
| -65% | -$1.75M |
|
91
Evolent Health
EVH
$1.11B
| $956K | 0.09% |
+50,000
| New | +$956K |
|
|
AUGX
92
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $880K | 0.08% |
1,000,000
+200,000
| +25% | +$176K |
|
93
Bruker
BRKR
$4.45B
| $383K | 0.04% |
6,000
-14,000
| -70% | -$893K |
|
|
ALPN
94
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-85,500
| Closed | -$3.39M |
|
|
SWAV
95
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-64,000
| Closed | -$20.8M |
|
96
Zimmer Biomet
ZBH
$20.8B
| – | – |
-67,500
| Closed | -$8.91M |
|
97
NovoCure
NVCR
$1.35B
| – | – |
-495,307
| Closed | -$7.74M |
|
98
Intellia Therapeutics
NTLA
$1.26B
| – | – |
-48,000
| Closed | -$1.32M |
|